Comparison of two low-molecular weight heparins (LMWHs), tinzaparin and bemiparin, during hemodialysis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 43, Issue 7, 2005, Pages 335-338

  Christidou, F N ^a   Frangia, T K ^b   Bamichas, G I ^a   Gionanlis, L C ^a   Natse, T A ^a   Georgoulis, I E ^b   Sombolos, K I ^a,c  

^a Renal Unit   (Greece)

^b Hematology Laboratory   (Greece)

^c NONE   (Greece)

Author keywords

Bemiparin; Hemodialysis; LMWH; Tinzaparin

Indexed keywords

BEMIPARIN; BICARBONATE; IVOR; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ARTIFICIAL KIDNEY; BLOOD CLOTTING; BLOOD SAMPLING; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG SUBSTITUTION; EXTRACORPOREAL CIRCULATION; FEMALE; FIBRIN FORMATION; HEMODIALYSIS; HUMAN; INTERSTITIAL NEPHRITIS; LONG TERM CARE; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME;

EID: 22144465855     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP43335     Document Type: Article

References (8)

1. Cornelli U, Fareed J 1999 Human pharmacokinetics of low-molecular weight heparins. Semin Thromb Hemost 25 (Suppl 3): 57-61
2. Falkon L, Saenz-Campos D, Antonijoan R, Martin S, Barbanoj M, Fontcuberta J 1997 Bioavailability and pharmacokinetics of a new low-molecular weight heparin (RO-11) - a three-way crossover study in healthy volunteers. Thromb Haemost 77: 133-136
3. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE 2001 Heparin and low-molecular weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 119 (1 Suppl): 64S-94S
4. Grau E, Siguenza F, Maduell F Linares M, Olaso MA, Martinez R, Caridad A 1992 Low-molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis. Nephron 62: 13-17
5. Guillet B, Simon N, Jose Sampo J, Lorec-Penet AM, Portugal H, Berland Y, Dussol B, Brunet P 2003 Pharmacokinetics of the low-molecular weight heparin enoxaparin during 48 hours after bolus administration as an anticoagulant in hemodialysis. Nephrol Dial Transplant 18: 2348-2353
6. Lai KN, Wang AYM, Ho K, Szeto CC, Wong LKS, Yu AWY 1996 Use of low-molecular weight heparin in hemodialysis. Am J Kidney Dis 28: 721-726
7. Planes A 2003 Review of bemiparin sodium - a new second-generation low-molecular weight heparin and its applications in venous thromboembolism. Exp Opin Pharmacother 4: 1551-1561
8. Turpie A 2000 Can we differentiate the low-molecular weight heparins? Clin Cardiol 23 (Sappl): I4-I7